Equities

Tactile Systems Technology Inc

Tactile Systems Technology Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)15.94
  • Today's Change0.38 / 2.44%
  • Shares traded257.92k
  • 1 Year change+26.01%
  • Beta1.1265
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.

  • Revenue in USD (TTM)285.05m
  • Net income in USD15.45m
  • Incorporated2006
  • Employees992.00
  • Location
    Tactile Systems Technology Inc1331 Tyler St NE Ste 200MINNEAPOLIS 55413-1638United StatesUSA
  • Phone+1 (612) 355-5100
  • Fax+1 (612) 355-5101
  • Websitehttps://www.tactilemedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Atlantic International Corp313.06m-68.07m260.76m7.00--14.53--0.8329-5.55-5.5512.450.3584.44--10.4844,723,330.00-96.45-71.97-233.48-106.0910.8161.01-21.74-1,471.82---1.640.8328---100.00---37.43------
AngioDynamics, Inc.292.73m-243.03m273.87m748.00--1.41--0.9356-6.04-6.047.254.790.74342.276.55391,344.90-61.72-16.38-74.39-18.7051.7152.95-83.02-30.491.41--0.00---10.282.35-251.53--13.09--
Neuropace Inc76.45m-28.09m274.30m171.00--27.86--3.59-0.9924-0.99242.700.32990.78171.836.69447,087.70-28.72---33.44--73.83---36.74--4.77-4.060.8578--43.72--30.00------
OraSure Technologies, Inc.224.26m11.37m284.20m638.0025.300.667811.611.270.15060.15063.015.710.48622.645.58351,509.402.720.72382.940.821242.2646.945.591.1311.20--0.00040.004.6417.41413.1782.2010.18--
Clearpoint Neuro Inc30.43m-18.15m302.33m107.00--10.43--9.94-0.6912-0.69121.161.050.72421.509.66284,383.20-43.19-34.75-51.20-39.6760.3864.75-59.64-76.913.61--0.00--16.5626.64-34.40--75.30--
Delcath Systems Inc22.64m-34.12m307.91m76.00--31.48--13.60-1.36-1.360.83430.30590.57140.90946.34297,947.40-86.11-116.57-156.17-243.2181.3171.02-150.70-1,235.371.03-172.600.1892---24.05-9.53-30.60---5.26--
Cerus Corp197.91m-19.73m308.29m288.00--5.76--1.56-0.1076-0.10761.080.28821.001.977.88687,194.40-10.01-25.99-15.26-40.6260.5261.90-10.00-35.811.92-1.190.6057---0.806119.6912.37--32.07--
CVRx Inc47.26m-58.48m328.04m200.00--5.02--6.94-2.71-2.712.192.690.40380.6576.14236,275.00-49.96---54.21--84.16---123.75--10.23-17.040.4302--74.89--0.5528------
Nano-X Imaging Ltd10.13m-57.47m344.55m164.00--1.97--34.02-0.9974-0.99740.17552.990.0482--6.8961,756.10-27.33-30.98-29.96-35.10-81.80---567.41-1,527.245.09--0.0181--15.47--46.33--114.35--
MaxCyte Inc45.60m-35.74m368.13m143.00--1.72--8.07-0.3420-0.34200.43682.030.1770.55767.17318,878.30-13.87-13.18-14.86-14.3385.9888.79-78.37-62.969.22--0.00---6.7219.89-60.89--39.13--
ZimVie Inc451.30m-47.73m372.31m2.60k--0.9152--0.825-1.77-13.1616.6014.740.3941.144.04173,575.00-4.17---4.81--63.1865.51-10.58-8.731.38-0.62640.3514---1.26-16.08-19.50---23.70--
Tactile Systems Technology Inc285.05m15.45m373.39m992.0024.201.8016.861.310.6430.64311.918.660.98126.206.80287,349.805.320.90156.201.0951.4449.105.420.83093.80--0.11460.0011.2013.81259.6033.91-23.62--
Alpha Teknova Inc36.35m-31.68m412.57m210.00--4.73--11.35-0.7366-0.73660.8341.640.27703.127.44173,081.00-24.14---25.92--17.71---87.17--3.94-75.860.133---11.43--22.52------
Quanterix Corp129.33m-39.71m422.94m441.00--1.26--3.27-1.04-1.043.408.770.30782.374.60293,265.30-9.45-15.96-10.30-17.6657.4252.79-30.71-53.798.99--0.00--15.9626.6066.56--20.07--
Semler Scientific Inc58.94m15.91m430.67m92.0028.924.9426.027.312.052.057.5811.990.686817.209.33640,619.6018.5438.8320.3744.4188.0590.2227.0032.583.09--0.00--20.2825.9843.6932.64-0.3821--
Pacific Biosciences of California Inc173.15m-394.24m468.75m796.00--1.04--2.71-1.46-1.460.641.650.10341.975.78217,521.40-23.55-16.19-25.40-17.8123.8137.35-227.69-136.218.64-21.870.6634--56.2920.592.39--36.68--
Data as of Nov 21 2024. Currency figures normalised to Tactile Systems Technology Inc's reporting currency: US Dollar USD

Institutional shareholders

56.85%Per cent of shares held by top holders
HolderShares% Held
Morgan Stanley & Co. LLCas of 30 Sep 20242.23m9.32%
Cadian Capital Management LPas of 30 Sep 20241.93m8.07%
BlackRock Fund Advisorsas of 30 Sep 20241.91m7.98%
Paradigm Capital Management, Inc.as of 30 Sep 20241.66m6.95%
The Vanguard Group, Inc.as of 30 Sep 20241.44m6.03%
Macquarie Asset Management, Inc.as of 13 Mar 20241.20m5.02%
DWS Investments (UK) Ltd.as of 30 Sep 2024878.98k3.67%
TIAA-CREF Investment Management LLCas of 30 Sep 2024837.02k3.49%
Dimensional Fund Advisors LPas of 30 Sep 2024787.85k3.29%
Wasatch Advisors LPas of 30 Sep 2024727.19k3.03%
More ▼
Data from 30 Sep 2024 - 07 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.